Viewing Study NCT02158169


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:41 PM
Study NCT ID: NCT02158169
Status: COMPLETED
Last Update Posted: 2015-07-28
First Post: 2014-06-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module